Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection

Netherlands Journal of Medicine

Volumn 61, Issue 6, 2003, Pages 218-222

  de Boer, S Y ^a   Meeberg, P C V D ^a   Siem, H ^a   de Boer, W A ^b  

^a SLINGELAND HOSPITAL   (Netherlands)

^b BERNHOVEN HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PANTOPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; UREASE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTACID AGENT; ANTIINFECTIVE AGENT; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; BISMUTH; DRUG DERIVATIVE; OMEPRAZOLE; SULFOXIDE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROSCOPY; HEADACHE; HEALTH CARE FACILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALAISE; MALE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; PEPTIC ULCER; PROSPECTIVE STUDY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; TREATMENT FAILURE; TREATMENT OUTCOME; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; MIDDLE AGED;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ANTACIDS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BENZIMIDAZOLES; BISMUTH; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; SULFOXIDES; TETRACYCLINE;

EID: 0141574295     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hopkins RJ, Girardi LS, Turney EA. Relationship between H. pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996;110:1244-52.
2. Doorn LJ van, Schneeberger PM, Novhan N, Plaisier AP, Quint WGV, Boer WA de. Importance of Helicobacter pylori CAG-A and VAC-A status for the efficacy of antibiotic treatment. Gut 2000;46:321-6.
3. Houben MHMG, Beek D van de, Hensen EF, Craen ASM de, Rauws EAS, Tytgat GNS. A systematic review of Helicobacter pylori eradication therapy. The impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047-55.
4. Kung NNS, Sung JJY, Yuen NWF, et al. Anti-Helicobacter pylori treatment in bleeding ulcers: randomised controlled trial comparing 2-day versus 7-day bismuth quadruple therapy. Am J Gastroenterol 1997;92:438-41.
5. Boer WA de, Driessen WWM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:633-8.
6. Boer WA de, Etten RJXM van, Schade RBW, Ouwehand ME, Scheeberger PM, Tytgat CNJ. 4-day lansoprazole quadruple therapy is very effective in curing Helicobacter pylori infection. Am J Gastroenterol 1996;91:1778-82.
7. Boer SY de, Siem TH. Four day quadruple therapy as a routine treatment for Helicobacter pylori infection. Aliment Pharmacol Ther 1997;11:1119-21.
8. Boer WA de, Etten RJXM van, Schneeberger PM. Four-day Lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection. Neth J Med 1998;52:10-5.
9. Boer WA de, Driessen WMM, Jansz AR, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
10. Arvind AS, Cook RS, Tabaqchali S, Farthing MJG. One minute endosccopy room test for Campylobacter pylori. Lancet 1988;1/8587:704.
11. Boer WA de, Thys JC, Borody TJ, Graham DY, O'Morain C, Tytgat GNJ. Proposal for use of a standard side effect scoring system in studies exploring H. pylori treatment regimens. Eur J Gastroenterol Hepatol 1996;8:641-3.
12. O'Morain C, Borody A, Boer WA de, et al. Efficacy and safety of single triple capsules of bismuth citrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study. Aliment Pharmacol Ther 2003;17:415-20.
13. Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomised comparison of quadruple and triple therapies for Helicobacter pylori eradication: the quadrate study. Gastroenterology 2002;123:1763-9.
14. Boer WA de. Strategies for therapy failures: choice of 'back-up' regimen determined by primary treatment for Helicobacter pylori infection. In: Hunt RH, Tytgat GNS (eds). Helicobacter pylori basic mechanisms to clinical cure 2000. Dordrecht: Kluwer Academic Publishers, 2000:609-22.
15. Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus report. Aliment Pharmacol Ther 2002;16:167-80.
16. Chan FKL, Yung MY, Ling TKW, Leung WK, Chung SCS. What is the true impact of metronidazole resistance on the efficacy of bismuth triple therapy? Gut 1998;43(suppl 2):A85.
17. Borody TJ, Andrews P, Shortis NP, Hyland I. Seven day therapy for Helicobacter pylori. Gastroenterology 1995;108:A62.
18. Vautier G, Scott BB. A one week quadruple regimen for Helicobacter pylori in routine clinical practice. Aliment Pharmacol Ther 1997;1:107-8.
19. Boer WA de, Etten RJXM van, Lai JYL, Schneeberger PM, Wouw BAM van de, Driessen WMM. Effectiveness of quadruple therapy using lansoprazole instead of omeprazole in curing Helicobacter pylori infection. Helicobacter 1996;1:145-50.
20. Gomollon F, Gimeno L, Valdeperez S, Yus J, Marzo J, Perez-Caballero. Eradication of Helicobacter pylori among patients from a primary care practice. J Fam Pract 1996;43:551-5.
21. Lai Yjl, Grauw JC de, Boer WA de. Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease. Fam Pract 1999;16:483-8.
22. Borody TJ, Andrews P, Fraccuia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
23. Boer WA de, Etten RJXM van, Coremans A, Schneeberger PM. Two-day 'weekend' lansoprazole quadruple therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1998;12:77-81.
24. European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997;41:8-13.
25. Annibale B, D'Ambra G, Luzzi I, et al. Does pre-treatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients. Am J Gastroenterol 1997;92:790-4.